iCAD to Report Third Quarter 2022 Financial Results on November 10, 2022

NASHUA, N.H.,
Oct. 27, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology
leader providing innovative cancer detection and therapy solutions, today
announced that it will release financial results for the third quarter ended
September 30, 2022, after the market close, and host a conference call at 4:30
PM Eastern Time on November 10, 2022.

About
iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader
providing innovative cancer detection and therapy solutions. For more
information, visit www.icadmed.com.

Media
Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com

Investor
Inquiries:
iCAD Investor Relations
ir@icadmed.com